Option Care Health, Inc. (OPCH) Stock Price & Analysis
Option Care Health, Inc. (OPCH) rose 5.13% to USD 21.11 as of June 10, 2026 at 00:43 UTC, according to Nexqual real-time market data.
OPCH last closed at USD 20.08; the session ranged USD 20.33–21.14 on volume of 3,983,528 shares. Market capitalization is $3.31B, with a 52-week range of USD 18.01–36.8 (NMS). Source: Nexqual, June 10, 2026 at 00:43 UTC.
Key Statistics (as of June 10, 2026 at 00:43 UTC)
| Price | USD 21.11 |
|---|---|
| Change | ▲ 5.13% (up) |
| Previous Close | USD 20.08 |
| Open | USD 20.34 |
| Day Range | USD 20.33 – 21.14 |
| 52-Week Range | USD 18.01 – 36.8 |
| Volume | 3,983,528 shares |
| Market Cap | $3.31B |
| Exchange | NMS |
Technical Analysis (OPCH)
Nexqual's technical model rates OPCH "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 00:43 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.19 (neutral) |
| vs SMA50 | Below (USD 23.9) |
| MACD | -0.84 (negative) |
Analyst Ratings (OPCH)
Wall Street analysts rate OPCH "Buy" based on 11 analysts, with a mean price target of USD 29.18 (range USD 22–39), per Nexqual as of June 10, 2026 at 00:43 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 29.18 |
| High Target | USD 39 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 10 / 2 / 0 |
Earnings (OPCH)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.48 |
| Revenue Estimate | $1.42B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.4 vs est 0.37 ▲ beat |
| 2025-12-31 | USD 0.46 vs est 0.47 ▼ miss |
| 2025-09-30 | USD 0.45 vs est 0.43 ▲ beat |
| 2025-06-30 | USD 0.41 vs est 0.4 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:43 UTC.
Financials & Fundamentals (OPCH)
| Total Revenue | $5.67B |
|---|---|
| Revenue Growth (YoY) | +1.30% |
| Gross Margin | +19.18% |
| Operating Margin | +5.37% |
| Profit Margin | +3.64% |
| ROE | +15.26% |
| Debt / Equity | 94.01 |
| Current Ratio | 1.64 |
| Total Cash | $181.85M |
| Total Debt | $1.27B |
| Free Cash Flow | $168.69M |
Source: Nexqual, June 10, 2026 at 00:43 UTC.
Financial Health Score (OPCH)
Nexqual rates Option Care Health, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:43 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 19%, operating 5% |
| Balance Sheet | Mixed — $182M cash vs $1.27B debt |
| Cash Flow | Mixed — FCF $169M, slim 3.0% margin |
| Efficiency | Solid — ROE 15%, ROA 6.2% |
Ownership (OPCH)
| Insider Ownership | +1.20% |
|---|---|
| Institutional Ownership | +110.11% |
| Shares Outstanding | 157.03M |
| Float | 146.76M |
| Short % of Float | +10.97% |
Source: Nexqual, June 10, 2026 at 00:43 UTC.
Leadership (OPCH)
Option Care Health, Inc. is led by John Charles Rademacher (age 58), CEO, President & Director, per Nexqual as of June 10, 2026 at 00:43 UTC.
| CEO, President & Director | John Charles Rademacher (age 58) |
|---|---|
| Executive VP & CFO | Meenal Anil Sethna (age 55) |
| Chief Operating Officer | Luke Whitworth (age 44) |
| Chief Technology Officer | Brett Michalak |
Major Backers & Investors (OPCH)
Notable institutional backers of Option Care Health, Inc. include Wellington Management, Durable Capital Partners Lp, Fuller & Thaler Asset Management Inc., according to Nexqual as of June 10, 2026 at 00:43 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 7.58% |
| Durable Capital Partners Lp | 5.73% |
| Fuller & Thaler Asset Management Inc. | 4.54% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 4.33% |
| FMR, LLC | 4.09% |
| Arrowstreet Capital, Limited Partnership | 2.7% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 22.34% |
| BlackRock | 18.47% |
| State Street | 3.74% |
| Geode Capital | 2.71% |
Source: Nexqual, June 10, 2026 at 00:43 UTC.
From Option Care Health, Inc.'s Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Option Care Health, Inc. offers home and alternate site infusion services in the United States.
- It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
- The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGRY | Surgery Partners, Inc. | USD 13.96 | ▲ 1.82% |
| EHC | Encompass Health Corporation | USD 104.19 | ▲ 0.17% |
| PRVA | Privia Health Group, Inc. | USD 22.17 | ▲ 2.5% |
| PNTG | The Pennant Group, Inc. | USD 32.77 | ▲ 3.34% |
| LIVN | LivaNova PLC | USD 77.17 | ▲ 6.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:43 UTC. This page is informational and not investment advice.